https://www.selleckchem.com/pr....oducts/jak-inhibitor
To evaluate the characteristics and treatment outcomes of patients with pediatric Langerhans cell histiocytosis (LCH) with thymic involvement. We retrospectively described the clinical, biological, and imaging characteristics of a series of 19 patients with pediatric LCH with thymic involvement in our center between September 2016 and December 2019. We further analyzed the treatment response and outcomes of patients treated with chemotherapy or targeted therapy. Thymic involvement was found in 4.4% of a 433-consecutive pediatric
Like
Comment
Share
